Taken together, these findings indicate that induction of E-cadherin expression is necessary for Bit1 to inhibit lung cancer cell motility and further suggest that E-cadherin is a downstream target of Bit1 in repressing EMT. The gene discussed is PTRH2; the disease is lung carcinoma.